Trial intelligence / Profile preview

Safety and Immunogenicity of DTaP and 7vPnC Co-administration in Healthy Japanese Infants

NCT01250756Phase 4Completed

Sponsor
Pfizer
Start
Nov 2010
Primary completion
Mar 2012
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

A Phase 4 trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection, sponsored by Pfizer. Started Nov 2010; status: completed.

02

Drugs

pneumococcal 7-valent conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT01250756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01250756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call